Table 4.
Association of anti-GP2, ASCA, and PAB with disease characteristics in CD:pvalues for elevated (bold) or diminished (italic) prevalence of samples with anti-GP2, ASCA, or PAB in 169 CD patients detected by ELISAs and IIF, respectively
| |
anti-GP2 |
ASCA |
PAB |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
| IgA | IgG | IgA or IgG | IgA and IgG | IgA | IgG | IgA or IgG | IgA and IgG | > = 1/20 | > = 1/40 | |
| L1 |
|
|
|
|
|
|
|
|
|
|
| L2 |
<0.02 |
<0.002 |
<0.001 |
<0.03 |
|
|
<0.02 |
|
|
<0.05 |
| L3 |
|
<0.05 |
<0.05 |
|
|
<0.05 |
<0.002 |
|
|
|
| L4 |
|
|
|
|
|
|
|
|
|
|
| B1 |
|
|
|
|
|
|
|
|
|
|
| B2 |
|
|
|
|
|
|
|
|
|
|
| B3 |
|
<0.02 |
<0.04 |
|
|
|
|
|
|
|
| B1p |
|
|
|
|
|
|
|
|
|
|
| B2p |
|
<0.02 |
<0.02 |
|
|
|
|
|
|
|
| B3p |
|
<0.05 |
|
|
|
|
|
|
|
|
| A1 |
|
<0.004 |
<0.009 |
<0.001 |
|
<0.004 |
|
|
<0.002 |
<0.001 |
| A2 |
|
|
|
|
|
|
|
|
|
|
| A3 | <0.02 | |||||||||